During the past decade, Onkologikoa conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 17 clinical trials were completed, i.e. on average, 77.3% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 10 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Onkologikoa" #1 sponsor was "Spanish Breast Cancer Research Group" with 11 trials, followed by "Hoffmann-La Roche" with 8 trials sponsored, "MedSIR" with 3 trials sponsored, "Agenus Inc." with 1 trials sponsored and "Calithera Biosciences, Inc" with 1 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Onkologikoa" #1 collaborator was "Hoffmann-La Roche" with 4 trials as a collaborator, "Pfizer" with 4 trials as a collaborator, "Bristol-Myers Squibb" with 2 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator and "Sanofi" with 2 trials as a collaborator. Other collaborators include 16 different institutions and companies that were collaborators in the rest 26 trials.

According to Clinical.Site data, the most researched conditions in "Onkologikoa" are "Breast Cancer" (17 trials), "Breast Neoplasms" (4 trials), "Metastatic Melanoma" (2 trials), "Advanced Breast Cancer" (1 trials) and "Advanced Cholangiocarcinoma" (1 trials). Many other conditions were trialed in "Onkologikoa" in a lesser frequency.

Most popular intervention types in "Onkologikoa" are "Drug" (35 trials), "Behavioral" (2 trials), "Other" (2 trials), "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Docetaxel" (9 trials), "Cyclophosphamide" (6 trials), "Epirubicin" (5 trials), "Paclitaxel" (5 trials) and "Trastuzumab" (5 trials). Other intervention names were less common.

The vast majority of trials in "Onkologikoa" are 21 trials for "All" genders, 21 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Onkologikoa". undefined are not yet recruiting, 6 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 23 completed trials in Onkologikoa, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Onkologikoa, 5 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".